Brief: Acer Therapeutics And Relief Therapeutics Announce Receipt Of Notice Of Allowance Of US Patent Application Covering A Kit Comprising Phenylbutyrate And Sodium Benzoate
03/10/2022 13:58
Oct 3 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE RECEIPT
OF
NOTICE OF ALLOWANCE OF US PATENT APPLICATION COVERING A KIT
COMPRISING PHENYLBUTYRATE AND SODIUM BENZOATE
Source text for Eikon: ID:nGNX54pXFY
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31